Science to practice: Will gadolinium-enhanced MR imaging be useful in assessment of at-risk pregnancies?

Richard W Katzberg, John P McGahan

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Abstract

By assessing the maternofetal pharmacokinetics of a nonspecific extracellular gadolinium chelate in pregnant mice, Mühler et al(1)have shown that exposure to small amounts of a gadolinium chelate after injection in the mother is a reversible phenomenon, thereby reducing fetal exposure. These results have encouraging implications for the safety of contrast material-enhanced magnetic resonance(MR) imaging during human pregnancy in the third trimester.

Original languageEnglish (US)
Pages (from-to)325-326
Number of pages2
JournalRadiology
Volume258
Issue number2
DOIs
StatePublished - Feb 2011

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Science to practice: Will gadolinium-enhanced MR imaging be useful in assessment of at-risk pregnancies?'. Together they form a unique fingerprint.

Cite this